vs

Side-by-side financial comparison of Mount Logan Capital Inc. (MLCI) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Sol-Gel Technologies Ltd. is the larger business by last-quarter revenue ($17.3M vs $11.4M, roughly 1.5× Mount Logan Capital Inc.). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs -117.5%, a 184.7% gap on every dollar of revenue.

180 Degree Capital Corp. is a publicly traded registered closed-end management investment company.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

MLCI vs SLGL — Head-to-Head

Bigger by revenue
SLGL
SLGL
1.5× larger
SLGL
$17.3M
$11.4M
MLCI
Higher net margin
SLGL
SLGL
184.7% more per $
SLGL
67.3%
-117.5%
MLCI

Income Statement — Q3 FY2025 vs Q2 FY2025

Metric
MLCI
MLCI
SLGL
SLGL
Revenue
$11.4M
$17.3M
Net Profit
$-13.4M
$11.6M
Gross Margin
Operating Margin
-97.3%
65.1%
Net Margin
-117.5%
67.3%
Revenue YoY
217.7%
Net Profit YoY
487.6%
EPS (diluted)
$-1.64
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MLCI
MLCI
SLGL
SLGL
Q3 25
$11.4M
Q2 25
$17.3M
Q2 24
$5.4M
Q2 23
$594.0K
Q2 22
$3.5M
Net Profit
MLCI
MLCI
SLGL
SLGL
Q3 25
$-13.4M
Q2 25
$11.6M
Q2 24
$2.0M
Q2 23
$-6.0M
Q2 22
$-134.0K
Operating Margin
MLCI
MLCI
SLGL
SLGL
Q3 25
-97.3%
Q2 25
65.1%
Q2 24
29.9%
Q2 23
-1098.8%
Q2 22
-13.2%
Net Margin
MLCI
MLCI
SLGL
SLGL
Q3 25
-117.5%
Q2 25
67.3%
Q2 24
36.4%
Q2 23
-1005.1%
Q2 22
-3.8%
EPS (diluted)
MLCI
MLCI
SLGL
SLGL
Q3 25
$-1.64
Q2 25
$4.17
Q2 24
$0.71
Q2 23
$-0.22
Q2 22
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MLCI
MLCI
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$24.3M
Total DebtLower is stronger
$73.4M
Stockholders' EquityBook value
$131.2M
$31.9M
Total Assets
$1.6B
$39.3M
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MLCI
MLCI
SLGL
SLGL
Q3 25
Q2 25
$24.3M
Q2 24
$26.5M
Q2 23
$33.5M
Q2 22
$15.6M
Total Debt
MLCI
MLCI
SLGL
SLGL
Q3 25
$73.4M
Q2 25
Q2 24
Q2 23
Q2 22
Stockholders' Equity
MLCI
MLCI
SLGL
SLGL
Q3 25
$131.2M
Q2 25
$31.9M
Q2 24
$34.9M
Q2 23
$48.3M
Q2 22
$50.4M
Total Assets
MLCI
MLCI
SLGL
SLGL
Q3 25
$1.6B
Q2 25
$39.3M
Q2 24
$42.0M
Q2 23
$55.1M
Q2 22
$55.0M
Debt / Equity
MLCI
MLCI
SLGL
SLGL
Q3 25
0.56×
Q2 25
Q2 24
Q2 23
Q2 22

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MLCI
MLCI
SLGL
SLGL
Operating Cash FlowLast quarter
$-25.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MLCI
MLCI
SLGL
SLGL
Q3 25
$-25.6M
Q2 25
Q2 24
Q2 23
$-8.3M
Q2 22
Free Cash Flow
MLCI
MLCI
SLGL
SLGL
Q3 25
Q2 25
Q2 24
Q2 23
$-8.4M
Q2 22
FCF Margin
MLCI
MLCI
SLGL
SLGL
Q3 25
Q2 25
Q2 24
Q2 23
-1419.0%
Q2 22
Capex Intensity
MLCI
MLCI
SLGL
SLGL
Q3 25
Q2 25
Q2 24
Q2 23
15.8%
Q2 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons